Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 5 Parkinson's papers of 794 | 0.76 |
| pathways Reactome | 15 pathways; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 10661
Sealed predictions
- SUMO2 in dopamine neurons, braak+0.45 (p 0.224) → -0.04 (p 0.927)receipt 10668
Swarm cases
receipt 10668: SUMO2 in dopamine neurons, braak
- power
- full sample +0.18 (p 0.487, n 18), 95% CI -0.32 to +0.59. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.22 (p 0.379, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.38 (p 0.118, n 18). could be the mix.
- skeptic
- leave-one-out range +0.07 to +0.33, sign flips 0; without severely affected donors +0.18 (p 0.487, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SUMO2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts